Yaoshi Technology: As of March 10, 2026, the company has 43,087 shareholders.

robot
Abstract generation in progress

Securities Star News, YaoShi Technology (300725) responded to investor questions on the investor relations platform on March 23.

Investor: May I ask how many shareholders the company has as of March 10? Thank you.

YaoShi Technology Secretary: Hello, investor! As of March 10, 2026, the company has 43,087 shareholders.

Investor: Does the company currently have contact with other pharmaceutical companies or industry capital to explore strategic investments, equity cooperation, or joint R&D? Are there plans to introduce industry investors in the future to jointly promote AI drug development or CDMO business?

YaoShi Technology Secretary: Hello, investor! The company always maintains an open attitude, paying attention to and exploring various cooperation opportunities that can enhance the company’s core competitiveness and promote sustainable development of its main business, including strategic, R&D, and business collaborations with pharmaceutical companies and industry capital. The company always adheres to the interests of all shareholders and long-term development, carefully evaluating potential cooperation opportunities. If any relevant cooperation meets disclosure standards in the future, the company will strictly comply with laws, regulations, and regulatory requirements to disclose information in a timely manner. Currently, there are no major cooperation matters that should be disclosed but have not been disclosed. All significant information will be based on announcements published on Juchao Information Network. Thank you!

The above content is compiled from public information by Securities Star, generated by AI algorithms (Wangxin Algorithm Backup 310104345710301240019), and does not constitute investment advice.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin